Antiva Biosciences Revenue and Competitors

Location

#3431

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Antiva Biosciences's estimated annual revenue is currently $5.1M per year.(i)
  • Antiva Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Antiva Biosciences has 33 Employees.(i)
  • Antiva Biosciences grew their employee count by 57% last year.

Antiva Biosciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
SVP, Pharmaceutical Development and ManufacturingReveal Email/Phone
4
ControllerReveal Email/Phone
5
SVP Nonclinical Development and Global Health StrategyReveal Email/Phone
6
Director, Product Development and ManufacturingReveal Email/Phone
7
President & CEOReveal Email/Phone
8
Senior Virology AdviserReveal Email/Phone
9
Sr. HR Consultant/Acting Head HRReveal Email/Phone
10
Acting CFOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Antiva Biosciences?

Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. We aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HPV. Our lead programs are in clinical trials in high grade anal intraepithelial neoplasias (AIN 2,3) and high grade cervical intraepithelial neoplasias (CIN 2,3). The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego and builds on his anti-viral expertise as co-founder of Triangle Pharmaceuticals and Chimerix. Antiva's chemistry platform has yielded over two hundred proprietary pro-drug compounds that are designed to enhance the therapeutic index of known, potent antivirals.

keywords:N/A

N/A

Total Funding

33

Number of Employees

$5.1M

Revenue (est)

57%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M330%N/A
#2
$7.1M333%N/A
#3
$5.4M336%$44.7M
#4
$9.8M34-37%$200.9M
#5
$7.3M3410%N/A